(IPCI) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 19, 2013
(Benzinga,
10/18/10)
Intellipharmaceutics International Inc. (Nasdaq: IPCI) today announced that the Food and Drug Administration has accepted for filing its abbreviated new drug application for a generic version of Protonix®.
Protonix inhibits gastric...(read more)
Intellipharmaceutics (IPCI) Company Overview
There is no analysis for IPCI yet. But you can go to Wikinvest to help create one!
